Research Library
749 papers · 104 analysis articles
Research Analysis
Curated deep-dives into the latest peptide research
Exploring BPC-157 Safety and Pharmacokinetics: A Phase I Trial
BPC-157 Study Shows Promise in Accelerating Recovery from Hamstring Injuries
FDA Paves Way for New Testosterone Therapy Research in Men
Semaglutide Injection Remains on Market; FDA Clears Path for Continued Use
FDA Extends Pharmacy Compounding Advisory Committee’s Charter for Peptide Research and Patient Safety
FDA Proposes to Restrict Use of Semaglutide and Other Peptide Drugs in Compound Form
Papers Database
Effect of thymosin α1 on Immune response and organ function in acute aortic dissection surgery: PANDA II trial protocol.
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics.
Effect of Semaglutide on Physical Function, Body Composition, and Biomarkers of Aging in Older Adults With Overweight and Insulin Resistance: Protocol for an Open-Labeled Randomized Controlled Trial.
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial.
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma.
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity.
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
[The efficacy of semax in the tretament of patients at different stages of ischemic stroke].
Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.
Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.